Literature DB >> 3285470

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli.

A Skerra1, A Plückthun.   

Abstract

An expression system was developed that allows the production of a completely functional antigen-binding fragment of an antibody in Escherichia coli. The variable domains of the phosphorylcholine-binding antibody McPC603 were secreted together into the periplasmic space, where protein folding as well as heterodimer association occurred correctly. Thus, the assembly pathway for the Fv fragment in E. coli is similar to that of a whole antibody in the eukaryotic cell. The Fv fragment of McPC603 was purified to homogeneity with an antigen-affinity column in a single step. The correct processing of both signal sequences was confirmed by amino-terminal protein sequencing. The functionality of the recombinant Fv fragment was demonstrated by equilibrium dialysis. These experiments showed that the affinity constant of the Fv fragment is identical to that of the native antibody McPC603, that there is one binding site for phosphorylcholine in the Fv fragment, and that there is no inactive protein in the preparation. This expression system should facilitate future protein engineering experiments on antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285470     DOI: 10.1126/science.3285470

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  147 in total

1.  Intrabody construction and expression III: engineering hyperstable V(H) domains.

Authors:  P Wirtz; B Steipe
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 2.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

3.  Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domains.

Authors:  Marek Malecki; Annie Hsu; Lynn Truong; Sylvia Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Single-domain antibody fragments with high conformational stability.

Authors:  Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon G J Frenken; Serge Muyldermans; Lode Wyns; Andre Matagne
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

5.  Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

Authors:  H Tachibana; X J Cheng; K Watanabe; M Takekoshi; F Maeda; S Aotsuka; Y Kaneda; T Takeuchi; S Ihara
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 6.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

Review 7.  Recombinant human monoclonal antibodies. Basic principles of the immune system transferred to E. coli.

Authors:  P Fuchs; S Dübel; F Breitling; M Braunagel; I Klewinghaus; M Little
Journal:  Cell Biophys       Date:  1992 Aug-Dec

8.  Expression of a Chlamydia anticarbohydrate single-chain antibody as a maltose binding fusion protein.

Authors:  D P Malinowski; M Gourley; S Edelstein; R E Pearson
Journal:  Cell Biophys       Date:  1992 Aug-Dec

Review 9.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

Review 10.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.